High-dose calcineurin inhibitor-free everolimus as a maintenance regimen for heart transplantation may be a risk factor for Pneumocystis pneumonia-Reference-Cited by-同舟云学术

High-dose calcineurin inhibitor-free everolimus as a maintenance regimen for heart transplantation may be a risk factor for Pneumocystis pneumonia

Published:2017-06-08 Issue:4 Volume:19 Page:e12709
ISSN:1398-2273
Container-title:Transplant Infectious Disease
language:en
Short-container-title:Transpl Infect Dis

Author:

Hu Yu-Ning¹^ORCID,Lee Nan-Yao²,Roan Jun-Neng¹³,Hsu Chi-Hsin³⁴⁵,Luo Chwan-Yau¹⁶

Affiliation:

1. Division of Cardiovascular Surgery; Department of Surgery; National Cheng Kung University Hospital; College of Medicine; National Cheng Kung University; Tainan Taiwan

2. Division of Infection; Department of Internal Medicine; College of Medicine; National Cheng Kung University; Tainan Taiwan

3. Institute of Clinical Medicine; National Cheng Kung University Hospital and College of Medicine; Tainan Taiwan

4. Division of Critical Care Medicine; Department of Internal Medicine; National Cheng Kung University Hospital; College of Medicine; National Cheng Kung University; Tainan Taiwan

5. Division of Cardiology; Department of Internal Medicine; National Cheng Kung University Hospital; College of Medicine; National Cheng Kung University; Tainan Taiwan

6. Cardiovascular Research Center; National Cheng Kung University; Tainan Taiwan

Publisher

Wiley

Subject

Infectious Diseases,Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tid.12709/fullpdf

Reference31 articles.

1. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients;Eisen;N Engl J Med,2003

2. Everolimus-incorporated immunosuppressant strategy improves renal dysfunction while maintaining low rejection rates after heart transplantation in Japanese patients;Imamura;Int Heart J,2013

3. Multidisciplinary insights on clinical guidance for the use of proliferation signal inhibitors in heart transplantation;Zuckermann;J Heart Lung Transplant,2008

4. Everolimus: Efficacy and safety in cardiac transplantation;Schaffer;Expert Opin Drug Saf,2010

5. Opportunistic infections in patients with and patients without acquired immunodeficiency syndrome;Sepkowitz;Clin Infect Dis,2002

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How to diagnose and treat a patient without human immunodeficiency virus infection having Pneumocystis jirovecii pneumonia?;Clinical Microbiology and Infection;2023-08

2. Trends in the Epidemiology of Pneumocystis Pneumonia in Immunocompromised Patients without HIV Infection;Journal of Fungi;2023-07-31

3. New and Emerging Targeted Therapies for Vascular Malformations;American Journal of Clinical Dermatology;2020-06-15

4. Small-Molecule Protein Kinases Inhibitors and the Risk of Fungal Infections;Current Fungal Infection Reports;2019-12

5. m-TOR inhibitors and risk of Pneumocystis pneumonia after solid organ transplantation: a systematic review and meta-analysis;European Journal of Clinical Pharmacology;2019-08-03